This page shows what was measured, who it was measured in, and what that does not settle.
What Atropine Sulfate does in the body
Relaxation of the upper gastrointestinal tract and colon during hypotonic radiography
From the FDA-approved label: Atropine is an antimuscarinic agent since it antagonizes the muscarine-like actions of acetylcholine and other choline esters. Atropine inhibits the muscarinic actions of acetylcholine on structures innervated by postganglionic cholinergic nerves, and on smooth muscles which respond to endogenous acetylcholine but are not so innervated. , by using anticholinesterase agents which inhibit the enzymatic destruction of acetylcholine).
What happened in people
RNAWiki has not yet published a reviewed conclusion for this use.
§ A fixed RNAWiki sentence
Where this came from
Wording RNAWiki always uses, not a finding about this substance.
No reviewed claim names a result for any goal on this record.
No source is stored against this line.
The limit that matters most
Not recorded.
Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
RNAWiki has not recorded a supervision or regulatory status for this substance.
What the registries record it as
The substance registry classes this as chemical.
FDA substance registry · 7C0697DR9I · read 2026-08-29
Where each sentence above came from
No recorded sentence describes the change this makes in a way that stands on its own. The page opens with what it is taken for instead, and the recorded explanation follows below.
Shown as the opening line on this page.
No statement of the main limit is recorded.
The four opening statements run to 84 words.
Words this page uses
Four words worth knowing first
Chosen from what this page shows, with each one explained before the word it depends on.
Biomarker
A biomarker is a number from a test that stands in for something about health.
A picture of it, and where the picture fails
A biomarker is like a fuel gauge.
Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.
What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.
A measurable indicator used as a substitute for a clinical outcome of interest.
Placebo
A placebo is a dummy treatment given so the real one can be compared with it.
A picture of it, and where the picture fails
A placebo is like a blank control in an experiment.
Where that stops being true. A blank does nothing. People given a placebo often do get better.
What people get wrong. A placebo effect is read as imaginary. The improvement is measured and real.
An inactive intervention matched in appearance to the test intervention, used to control for non-specific effects.
Comparator
A comparator is whatever the treatment was measured against.
A picture of it, and where the picture fails
It is like the other runner in a race.
Where that stops being true. A race has one winner. A study can show both arms improved.
What people get wrong. Results are read without asking what the other group got. Beating nothing is not beating a treatment.
The control condition against which the experimental intervention is assessed.
What happened in people◇Read from sources, not yet reviewed
What happened in people
Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.
Postoperative Acute Kidney Injury
✗ The study did not show it
Who was studied
NCT02726620
How many people
22435
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Oral
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
PubChem PUG-REST · a recorded source, not a stored snapshot
Incidence of SER development of at least -1.0 dioptres (D)
✗ The study did not show it
Who was studied
NCT04045951
How many people
2138
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Oral
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
PubChem PUG-REST · a recorded source, not a stored snapshot
Incidence of SER development of at least -0.5 dioptres (D)
✗ The study did not show it
Who was studied
NCT04044755
How many people
2138
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Oral
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
PubChem PUG-REST · a recorded source, not a stored snapshot
Detection of obstructive CAD and prevalence of MACE in enrolled participants
✗ The study did not show it
Who was studied
NCT06185530
How many people
2000
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Oral
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
PubChem PUG-REST · a recorded source, not a stored snapshot
incidence of Postoperative myocardial injury after non-cardiac surgery(MINS)
✗ The study did not show it
Who was studied
NCT05635877
How many people
2000
Study design
Phase 4
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Oral
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
PubChem PUG-REST · a recorded source, not a stored snapshot
Mortality
✗ The study did not show it
Who was studied
NCT03925025
How many people
1728
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
Living longer, or avoiding a major event
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Oral
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
PubChem PUG-REST · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.
What is missing or unclear◇Read from sources, not yet reviewed
Were people like you studied?
RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.
Who was studied
People similar to this profile were included.
& USAGE Atropine sulfate is given parenterally as a preanesthetic medication to decrease salivation and bronchial secretions. It is useful in pylorospasm and other spastic conditions of the gastrointestinal tract. For ureteral and biliary colic, atropine sulfate given with morphine may be indicated.
Who is missing from the studies
Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
What the label states about particular groups
On pediatric, the label states: “Due to the potential for systemic absorption of atropine sulfate ophthalmic solution, the use of atropine sulfate ophthalmic solution, 1% in children under the age of 3 months is not recommended and the use in children under 3 years of age should be limited to no more than one drop per eye per day.”
US prescribing information · 1b2d030e-c0ec-484b-a228-76011702cdd0 · read 2026-08-30
On older people, the label states: “No overall differences in safety and effectiveness have been observed between elderly and younger adult patients.”
US prescribing information · 1b2d030e-c0ec-484b-a228-76011702cdd0 · read 2026-08-30
On people who are pregnant, the label states: “Category C: There are no adequate and well-controlled studies of atropine sulfate in pregnant women.”
US prescribing information · 1b2d030e-c0ec-484b-a228-76011702cdd0 · read 2026-08-30
On people who are breastfeeding, the label states: “Traces of atropine have been found in human milk following administration of atropine solution for injection.”
US prescribing information · 1b2d030e-c0ec-484b-a228-76011702cdd0 · read 2026-08-30
Where the result stopped carrying
This is a scope explorer, not a diagnosis engine.
It shows who was studied so you can see whether people similar to you were included.
RNAWiki cannot tell whether a study fits you. It can show who was in it.
What it would be like to take◇Read from sources, not yet reviewed
Why it might seem to do nothing
A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.
It was studied in different people
The people in the studies were not much like the reader.
On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
The evidence may simply be wrong
Small early studies often do not hold up.
On this record: RNAWiki has not yet published a reviewed conclusion for this use.
Other reasons RNAWiki checked and found nothing for (11)
It was studied for a different goal
The studies measured something else entirely. Nothing in this record points to this reason.
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.
None of these is a reason to take more. Taking more is not a step this page ever suggests.
What it would be like to take◇Read from sources, not yet reviewed
What taking it involves
The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.
How it is supplied
Prescription only
❝ Quoted from a source
Where this came from
Copied from a source RNAWiki stored, with the source named.
Read from the recorded approval status.
No source is stored against this line.
Form and route
Oral
✎ Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
The form and route recorded on this substance.
No source is stored against this line.
Who oversees it
RNAWiki has not recorded a supervision or regulatory status for this substance.
❝ Quoted from a source
Where this came from
Copied from a source RNAWiki stored, with the source named.
No register row and no identity class settled the question.
No source is stored against this line.
What is in the pack
Sold as tablet, injectable, solution, solution/drops, given by the oral, injection, intravenous, intramuscular, subcutaneous, intraosseous, endotracheal route.
✎ Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
Recorded notes on how this is sold and what that means for what is in the pack.
No source is stored against this line.
Where it is registered
Regulatory records are listed in the technical disclosure at the foot of this page.
# Counted from records
Where this came from
A count of rows RNAWiki holds. It describes our records, not your body.
Register entries are stored per jurisdiction and shown with their dates.
No source is stored against this line.
Why people stop
Not recorded.
∅ Nothing recorded
Where this came from
RNAWiki holds nothing here and says so rather than guessing.
No record of why people stopped taking it is stored for this substance.
No source is stored against this line.
What it would be like to take∅Nothing found in the sources checked
What can go wrong
Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.
∅Nothing found in the sources checked
No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.
The sources listed were searched and held nothing. That is not the same as nothing existing.
Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.
Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
What is missing or unclear◇Read from sources, not yet reviewed
Does the exact form matter?
Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.
The form that was studied
Oral
✎ Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
The form used in the studies cited on this page.
No source is stored against this line.
What is sold
Not recorded.
∅ Nothing recorded
Where this came from
RNAWiki holds nothing here and says so rather than guessing.
Nothing further is recorded about which forms are sold.
No source is stored against this line.
What is recorded as being sold
170 products list this as an active ingredient in the United States drug directory. 101 of them contain it and nothing else.
FDA National Drug Code directory · 71872-7252 · read 2026-08-29
They are sold as elixir, injection, injection, solution, liquid, ointment and powder, taken endotracheal, intramedullary, intramuscular and intravascular.
FDA National Drug Code directory · 71872-7252 · read 2026-08-29
The regulator's established pharmacologic class for it is anticholinergic [epc], cholinergic antagonists [moa] and cholinergic muscarinic antagonist [epc].
FDA National Drug Code directory · 71872-7252 · read 2026-08-29
124 published labels name it as an active ingredient. 62 of them describe this substance alone, which is where its own label text on this page comes from.
US prescribing information · e9fd624a-9abd-dfea-e053-2a95a90a8e9d · read 2026-08-29
Those labels are classed as human otc drug and human prescription drug.
US prescribing information · e9fd624a-9abd-dfea-e053-2a95a90a8e9d · read 2026-08-29
1 marketed supplement label lists this ingredient, classed as fat/fatty acid.
Those labels carry all other, nutrient and structure/function claims. A claim of that kind is written by the manufacturer and is not assessed by any regulator, so its presence says nothing about whether it is true.
Atropine is ophthalmic at 3., recorded as fda label in effect 2024-01-02 in the United States.
US prescribing information · 1b2d030e-c0ec-484b-a228-76011702cdd0 · read 2026-08-30
Recorded price in US: 3.91597–19.99768 USD per one millilitre, across 20 priced products whose strengths and pack forms differ, as of 2026-08-26, paid by retail pharmacies buying the product, as surveyed by the Centers for Medicare & Medicaid Services. It is not a list price, an insurance price, or what anyone pays at a counter..
Recorded source · 2026-08-26 · read 2026-08-28
Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.
What it would be like to take◇Read from sources, not yet reviewed
What you could measure
This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.
RNAWiki could not confidently classify this substance, so no self-experiment plan is offered.
Questions worth asking
Which of the trials of Atropine Sulfate studied people like me?
What was measured, and for how long?
Was the result a laboratory value or a health outcome?
What would we watch for, and when would we stop?
Tracking can show whether something changed for you. It cannot show what caused it.
RNAWiki records evidence. It does not say whether this substance is right for you.
What is missing or unclear◇Read from sources, not yet reviewed
What nobody knows yet
Open questions, each with why it is open and what would close it.
Missing populations
Which groups were under-represented in the studies has not been recorded.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing long-term data
No completed tested study window is recorded.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
No reviewed conclusion
RNAWiki has not yet published a reviewed conclusion for this use.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing interaction studies
No interaction was found in the registers checked. Not finding one is not the same as showing there is none.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Formulation uncertainty
Several salts, forms or products of Atropine Sulfate are recorded. Results from one form may not transfer to another.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Mechanism not reviewed
No reviewed mechanism story exists for this substance.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
What happened in people◇Read from sources, not yet reviewed
Check any of this yourself
Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.
How many documents were read
61 documents were read for this substance.
RNAWiki source record
Where else this substance is registered
FDA substance identifier (UNII)
7C0697DR9I
RxNorm concept
1190536
Checks this page had to pass
✓ Passed
Identity resolved
no open identity hold
✓ Passed
No unresolved merge across substance families
no quarantine open
✓ Passed
Every public sentence names a source
The opening statement carries the origin: Written into the record, not signed off.
✗ Not passed
Trial roles classified for highlighted evidence
No registered study is classified as testing this substance.
✓ Passed
No internal keys in reader text
enforced by the copy-contract test over the rendered page
✗ Not passed
Safety mode resolved
No register row and no identity class settled the question.
✓ Passed
Canonical metadata present
slug and display name present
What is missing or unclear◇Read from sources, not yet reviewed
How this medicine reached us
Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.
Withdrawn in United States, 2023, for "Presence of Particulate Matter; identified as glass" (openFDA drug enforcement Class I recall)
Withdrawn in United States, 2017, for "SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent" (openFDA drug enforcement Class I recall)
What the approval register records
75 approved applications cover products containing this substance. The earliest was NDA012462, approved 19600915 to PFIZER.
This order is fixed in code and does not count clicks or time on the page.
What is not here
9 questions this page could not answer
These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.
What was measured, goal by goal — found nothing in the sources checked.
How close this is to real life — found nothing in the sources checked.
The path through the body — found nothing in the sources checked.
Felt, measured, or meaningful — found nothing in the sources checked.
How long anything takes — found nothing in the sources checked.
What it may clash with — found nothing in the sources checked.
Other ways to the same goal — found nothing in the sources checked.
Claims that go past the evidence — found nothing in the sources checked.
What changed on this page — found nothing in the sources checked.
The record as stored
The full record, for auditing
Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.
Recorded evidence blocks (9)
Q1
On the Atropine Sulfate label: indicated for what?
"Atropine Sulfate Ophthalmic Solution, 1% is indicated in adults and pediatric patients aged three (3) months and older for: 1.1 Cycloplegia 1.2 Mydriasis 1.3 Penalization of the Healthy Eye in the Treatment of Amblyopia Atropine is an anti-cholinergic indicated in adults and pediatric patients aged three (3) months…": indications and usage on Atropine Sulfate's label. DailyMed label · a116af5c-ba4c-408c-9a02-4bc33772aa8d · 2026-08-03
Q2
98 registered trials of Atropine Sulfate — at which phases?
Registered studies posting no result
79 of 98
98 registered studies of Atropine Sulfate: 26 phase4, 20 phase3, 19 na, 16 phase2, 12 phase1, 6 early phase1, 3 na or unstated. CLINICALTRIALS_SNAPSHOT · 2026-09-01
1729 with a PubMed record
Show the evidence
phase4
26
phase3
20
na
19
phase2
16
phase1
12
early phase1
6
9 more recorded rows
na or unstated
3
completed
68
unknown
13
recruiting
5
withdrawn
4
active not recruiting
3
terminated
3
enrolling by invitation
1
not yet recruiting
1
recorded 2026-09-01 · last checked 2026-09-04
Q3
7 of Atropine Sulfate's trials stopped: safety, accrual/recruitment, other?
"Poor enrollment and infeasibility of ever reaching the necessary sample size"; 7 of 98 registered studies
Show the evidence
Trial
NCT00506675
terminated; "Poor enrollment and infeasibility of ever reaching the necessary sample size"
NCT03322150
terminated; "The research was terminated because the recruitment of the study subjects was not smooth and the overseas training of the investigator was scheduled."
NCT03718507
withdrawn; "no recrutiment started"
NCT03972683
withdrawn; "no participants enrolled"
NCT04393103
withdrawn; "no avilable resorces"
NCT04777383
terminated; "The study was terminated prematurely due to insufficient operational resources to continue trial conduct and completion. The decision was unrelated to safety concerns or study outcomes."
1 further recorded trialNCT05481489
withdrawn; "Due to sponsors convenience."
recorded 2026-09-01 · last checked 2026-09-04
Q4
Human studies of Atropine Sulfate used Atropine (0.01mg/kg) — over how long?
Human studies of Atropine Sulfate used "Atropine (0.01mg/kg)". ClinicalTrials.gov · 2026-09-01
20 recorded entries; human; ophthalmic; also "Atropine sulfate ophthalmic solution 1%", "0.125% atropine (Sinphar Pharmaceutical, Ilan, Taiwan)", "Atropine 0.24 mg"
Atropine Sulfate's half-life is 3 ± 1.2 hours — which schedules were studied?
3 ± 1.2 hours, the half-life Atropine Sulfate's label states: "Terminal half-life of l-hyoscamine was not affected by route of administration and was calculated to be 3 ± 1.2 hours (intravenous) and 2.5 ± 0.8 hours (topical ophthalmic)." DailyMed label · a116af5c-ba4c-408c-9a02-4bc33772aa8d · 2026-08-03
bioavailability 1 %.
Show the evidence
half lifepharmacokinetics
3 ± 1.2 hours; Terminal half-life of l-hyoscamine was not affected by route of administration and was calculated to be 3 ± 1.2 hours (intravenous) and 2.5 ± 0.8 hours (topical ophthalmic).
bioavailabilitypharmacokinetics
1 %; The bioavailability of atropine sulfate ophthalmic solution 1% was assessed in six healthy subjects, 24 to 29 years of age.
recorded 2026-08-03 · last checked 2026-09-04
Q6
Which 46 trials of Atropine Sulfate posted no result?
Posted no result
46 of 46 completed trials
Registrations
NCT00468091, NCT00001864, NCT00094614, NCT00094692, NCT00575523 and NCT00921102, and 40 more
Completion dates
oldest 2000-09; newest 2024-09-01
Show the evidence
Trial
NCT00468091
2000-09
NCT00001864
2001-11
NCT00094614
2003-04
NCT00094692
2005-12
NCT00575523
2008-01
NCT00921102
2008-05
14 further recorded trials
NCT00121524
2008-06
NCT00689208
2008-11
NCT00623207
2009-10
NCT01858090
2010-01
NCT00947596
2010-08
NCT00991627
2010-08
NCT00834470
2010-12
NCT01464489
2011-09
NCT00251602
2012-08
NCT02055378
2012-12
NCT02186132
2013-02
NCT01871922
2013-06
NCT00000170
2013-08
NCT02658721
2013-08
Q7
At the median, Atropine Sulfate's trials enrolled 70 people — anything larger?
Median enrolment
70
Largest enrolment
22435
Registered trials counted
98
Q8
What do 802 spontaneous reports say about Atropine Sulfate — and not say?
These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.
Atropine Sulfate appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 802 reaction mentions were counted: drug hypersensitivity 114; diarrhoea 111; hypotension 99; tachycardia 93. FAERS via Open Targets · CHEMBL2146146 · 2026-06-24
Show the evidence
drug hypersensitivity
114
diarrhoea
111
hypotension
99
tachycardia
93
bradycardia
85
hypertension
82
4 more recorded rows
toxicity to various agents
70
cardiac arrest
59
hyperhidrosis
46
heart rate increased
43
recorded 2026-06-24 · last checked 2026-09-04
Q9
Which 10 reactions does Atropine Sulfate's label not list?
2 label terms; 10 reported and unlisted; a116af5c-ba4c-408c-9a02-4bc33772aa8d
Show the evidence
bradycardia
count not stated
cardiac arrest
count not stated
diarrhoea
count not stated
drug hypersensitivity
count not stated
heart rate increased
count not stated
hyperhidrosis
count not stated
4 more recorded rows
hypertension
count not stated
hypotension
count not stated
tachycardia
count not stated
toxicity to various agents
count not stated
recorded 2026-06-24 · last checked 2026-09-04
Where it is registered
Where it’s registered
Withdrawn in United States, 2023, for "Presence of Particulate Matter; identified as glass" (openFDA drug enforcement Class I recall)
Withdrawn in United States, 2017, for "SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent" (openFDA drug enforcement Class I recall)
ChEMBL 37 — CC BY-SA 3.0 Unported · ClinicalTrials.gov — US Government work · Open Targets 26.06 — CC0 · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work · openFDA enforcement — US Government work
✗ required summary fields resolved: 4 required field(s) not terminal: Why people use it, Best-supported result, Biggest unanswered question, Human evidence
✓ public claims reviewed: 0 reviewed claim(s); drafts are never rendered
✓ source coverage passed: 7 source rows
✓ no critical contamination: no quarantine open
✓ canonical metadata passed: slug and display name present
✓ no raw internal fields: enforced by the copy-contract test over the rendered page
This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.